Company profile: Scioderm
1.1 - Company Overview
Company description
- Provider of clinical-stage topical products for the treatment of chronic skin diseases, focused on addressing critical medical needs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scioderm
Forge Biologics
HQ: United States
Website
- Description: Provider of end-to-end AAV gene therapy manufacturing and development services from preclinical to commercial stages, including plasmid DNA production (research-grade to cGMP), turnkey research-grade AAV via Blaze Vector Production using proprietary Ignition Cells, process and analytical development, cGMP production in 50L to 5,000L bioreactors, integrated regulatory solutions, and a 200,000+ sq. ft. cGMP facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Forge Biologics company profile →
Xinvento
HQ: The Netherlands
Website
- Description: Provider of a credible alternative treatment for congenital hyperinsulinism.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xinvento company profile →
Anthera
HQ: United States
Website
- Description: Provider of products to treat diseases associated with inflammation and autoimmune diseases, including Vernis Soin, a nail polish that also acts as a treatment formulated with essential oils of lavender, tea tree, and geranium to nourish, fortify, and protect nails.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anthera company profile →
Stealth Biotherapeutics
HQ: United States
Website
- Description: Provider of clinical-stage therapies targeting mitochondrial dysfunction, developing elamipretide to improve mitochondrial function for dry AMD, primary mitochondrial myopathy, Duchenne muscular dystrophy, and Barth syndrome, and SBT-272 for neurodegenerative diseases; conducts NuPOWER, TAZPOWER, and ReCLAIM-2 trials and offers an Expanded Access Program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stealth Biotherapeutics company profile →
Nivalis
HQ: United States
Website
- Description: Provider of clinical-stage pharmaceutical therapies designed to preserve intracellular S-nitrosoglutathione (GSNO), an endogenous molecule with cell signaling effects implicated in cystic fibrosis pathophysiology; developing a novel class of disease-modifying treatments, including lead candidate N91115 initially targeting CF patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nivalis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scioderm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scioderm
2.2 - Growth funds investing in similar companies to Scioderm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scioderm
4.2 - Public trading comparable groups for Scioderm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →